Our platform is a way to study fat cells outside a human or animal body, or in vitro. Our stem-cell platform, M3, is unique in its accuracy in replicating human fat cells.
Dr. Prakash is a drug discovery professional with over 20 years of experience in the pharmaceutical and biotechnology industry. He has brought countless new chemical entities to the clinical testing stage including an A1 receptor agonist for glaucoma and the first poly (ADP-ribose) polymerase inhibitor to enter clinical trials.
He currently holds over 40 US and international patents in the fields of new chemical entities, investigational drug processes, pharmacology, disease treatments, and inventor of clinical candidates.
Prakash currently serves as MelliCell's own Director of Medicinal Chemistry and plays a vital role in identifying, designing, and synthesizing potential drug candidates for our mission to cure type two diabetes.
Copyright © 2024 MelliCell. All Rights Reserved.